Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

Blog - Aerospace
Sep 2025
New 3D-Printable Titanium Alloy to Combat Climate Change
Pure titanium and titanium alloys, including Ti-6Al-4V, are used in aerospace applications for forming airframes and engine parts because of their light weight, high strength, and resistance to corrosion. However,...
News
Sep 2025
Carol Pitzel Cruz Named ‘Winning Litigator’ Finalist by The National Law Journal
Pitzel Cruz’s selection follows recent recognition as ‘Hatch-Waxman Litigator of the Year’ at LMG Life Sciences Awards SEATTLE, September 9, 2025 – Knobbe Martens is pleased to share that partner...
Blog - Trademark & Brand Protection
Sep 2025
Will the Bankruptcy of “Forever 21” Strengthen IP Rights?
For the second time since its founding in 1984, the fast-fashion movement leader, Forever 21, has filed for bankruptcy and is expected to close its over 350 U.S. locations and...